WHO To Resume Hydroxychloroquine Trials After Lancet Cautions Over Dodgy Study

Zero Hedge | The World Health Organization announced on Wednesday that it would resume trials involving hydroxychloroquine after The Lancet issued a major disclaimer over a study which prompted the WHO to halt ongoing trials, according to AFP.